Martin Tolar, MD, PhD, the president and CEO at Alzheon, talked about the recent discoveries made in understanding the pathology of Alzheimer disease and the development of innovative therapies to potentially set the stage for more effective care.

Read more: https://www.neurologylive.com/view/br...

Editor's note: There was an unfortunate issue with the audio for this interview. Our apologies for any inconvenience.